PRODUCTION OF POLYCLONAL ANTIBODIES AGAINST INDIAN CATTLE TICK RHIPICEPHALUS MICROPLUS SALIVA TOXINS AND ITS EFFICACY IN REVERSAL OF TOXIC EFFECTS IN ALBINO MICE Article Swipe
Nidhi Yadav
,
Ravi Kant Upadhyay
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.22159/ijpps.2023v15i11.48954
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.22159/ijpps.2023v15i11.48954
Objective: This study focuses on the generation of polyclonal antibodies against tick saliva toxins and its use to reverse the toxic effects in albino mice. Methods: Polyclonal antibodies were generated by immunizing albino mice were immunized with saliva toxins mixed with incomplete Freund’s adjuvant. Experimental mice were treated with antiserum (polyclonal antibodies) and pre-incubated with tick saliva toxins in five different groups for observation of reversal of toxic effects, i.e. levels of bio-molecules and enzymes. For detection of polyclonal antibodies in the antiserum immune double diffusion (IDD) test of Ouchterlony was followed. Results: By employing a step-by-step octanoic acid and ammonium sulphate precipitation process, IgG antibodies were separated from antiserum. A crescent band and precipitation band was obtained due to the interaction of antigen and antibodies in wet agarose gels (1%). When these antibodies were injected in albino mice, these have been successfully reversed the levels of acid phosphatase (ACP), alkaline phosphatase (ALP), glutamate pyruvate transaminase (GPT), glutamate oxaloacetate transaminase (GOT), lactic dehydrogenase (LDH) and acetylcholinesterase (AchE). Alkaline phosphate levels in the serum of albino mice injected with polyclonal antibodies were found to be 122.64%, 107.849%, and 104.71%, respectively. Glutamate pyruvate transaminase (GPT) has been reversed in mice treated with polyclonal antibodies up to 94.59%, 86.48% and 78.37% in the serum, while it was found to be 116.21% at 40% of 24-h LD50 dose in comparison to control respectively. Similarly, level of lactic dehydrogenase was restored and found i.e. 104.55%, 103.82%, and 102.20% in the serum of albino mice. Respectively, in comparison to control, while mice injected with 40% of 24-h LD50 of the purified saliva toxins demonstrated 117.20% of lactic dehydrogenase (LDH) level in comparison to control. Conclusion: Polyclonal antibodies administered for serotherapy reversed the toxic effects and all biochemical parameters become normal after 6 h of treatment in albino mice in comparison to control.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.22159/ijpps.2023v15i11.48954
- https://journals.innovareacademics.in/index.php/ijpps/article/download/48954/28967
- OA Status
- diamond
- References
- 40
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4388131889
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4388131889Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.22159/ijpps.2023v15i11.48954Digital Object Identifier
- Title
-
PRODUCTION OF POLYCLONAL ANTIBODIES AGAINST INDIAN CATTLE TICK RHIPICEPHALUS MICROPLUS SALIVA TOXINS AND ITS EFFICACY IN REVERSAL OF TOXIC EFFECTS IN ALBINO MICEWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-11-01Full publication date if available
- Authors
-
Nidhi Yadav, Ravi Kant UpadhyayList of authors in order
- Landing page
-
https://doi.org/10.22159/ijpps.2023v15i11.48954Publisher landing page
- PDF URL
-
https://journals.innovareacademics.in/index.php/ijpps/article/download/48954/28967Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
diamondOpen access status per OpenAlex
- OA URL
-
https://journals.innovareacademics.in/index.php/ijpps/article/download/48954/28967Direct OA link when available
- Concepts
-
Polyclonal antibodies, Antiserum, Alkaline phosphatase, Antibody, Saliva, Molecular biology, Lactate dehydrogenase, Biology, Transaminase, Chemistry, Biochemistry, Microbiology, Enzyme, ImmunologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
40Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4388131889 |
|---|---|
| doi | https://doi.org/10.22159/ijpps.2023v15i11.48954 |
| ids.doi | https://doi.org/10.22159/ijpps.2023v15i11.48954 |
| ids.openalex | https://openalex.org/W4388131889 |
| fwci | 0.0 |
| type | article |
| title | PRODUCTION OF POLYCLONAL ANTIBODIES AGAINST INDIAN CATTLE TICK RHIPICEPHALUS MICROPLUS SALIVA TOXINS AND ITS EFFICACY IN REVERSAL OF TOXIC EFFECTS IN ALBINO MICE |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | 18 |
| biblio.first_page | 11 |
| topics[0].id | https://openalex.org/T10296 |
| topics[0].field.id | https://openalex.org/fields/24 |
| topics[0].field.display_name | Immunology and Microbiology |
| topics[0].score | 0.9988999962806702 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2405 |
| topics[0].subfield.display_name | Parasitology |
| topics[0].display_name | Vector-borne infectious diseases |
| topics[1].id | https://openalex.org/T12477 |
| topics[1].field.id | https://openalex.org/fields/24 |
| topics[1].field.display_name | Immunology and Microbiology |
| topics[1].score | 0.9983000159263611 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2403 |
| topics[1].subfield.display_name | Immunology |
| topics[1].display_name | Toxin Mechanisms and Immunotoxins |
| topics[2].id | https://openalex.org/T11641 |
| topics[2].field.id | https://openalex.org/fields/11 |
| topics[2].field.display_name | Agricultural and Biological Sciences |
| topics[2].score | 0.9961000084877014 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1109 |
| topics[2].subfield.display_name | Insect Science |
| topics[2].display_name | Insect and Pesticide Research |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C956191 |
| concepts[0].level | 3 |
| concepts[0].score | 0.9170691967010498 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q930144 |
| concepts[0].display_name | Polyclonal antibodies |
| concepts[1].id | https://openalex.org/C91523082 |
| concepts[1].level | 3 |
| concepts[1].score | 0.7502971887588501 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q420496 |
| concepts[1].display_name | Antiserum |
| concepts[2].id | https://openalex.org/C160160445 |
| concepts[2].level | 3 |
| concepts[2].score | 0.735133171081543 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q24769688 |
| concepts[2].display_name | Alkaline phosphatase |
| concepts[3].id | https://openalex.org/C159654299 |
| concepts[3].level | 2 |
| concepts[3].score | 0.6083718538284302 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q79460 |
| concepts[3].display_name | Antibody |
| concepts[4].id | https://openalex.org/C504460877 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5668473839759827 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q155925 |
| concepts[4].display_name | Saliva |
| concepts[5].id | https://openalex.org/C153911025 |
| concepts[5].level | 1 |
| concepts[5].score | 0.48905977606773376 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q7202 |
| concepts[5].display_name | Molecular biology |
| concepts[6].id | https://openalex.org/C2777318727 |
| concepts[6].level | 3 |
| concepts[6].score | 0.48729407787323 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q409464 |
| concepts[6].display_name | Lactate dehydrogenase |
| concepts[7].id | https://openalex.org/C86803240 |
| concepts[7].level | 0 |
| concepts[7].score | 0.4377509653568268 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[7].display_name | Biology |
| concepts[8].id | https://openalex.org/C2776877979 |
| concepts[8].level | 3 |
| concepts[8].score | 0.4120270907878876 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q424288 |
| concepts[8].display_name | Transaminase |
| concepts[9].id | https://openalex.org/C185592680 |
| concepts[9].level | 0 |
| concepts[9].score | 0.40376269817352295 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[9].display_name | Chemistry |
| concepts[10].id | https://openalex.org/C55493867 |
| concepts[10].level | 1 |
| concepts[10].score | 0.3720472455024719 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[10].display_name | Biochemistry |
| concepts[11].id | https://openalex.org/C89423630 |
| concepts[11].level | 1 |
| concepts[11].score | 0.32297462224960327 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q7193 |
| concepts[11].display_name | Microbiology |
| concepts[12].id | https://openalex.org/C181199279 |
| concepts[12].level | 2 |
| concepts[12].score | 0.2071177363395691 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q8047 |
| concepts[12].display_name | Enzyme |
| concepts[13].id | https://openalex.org/C203014093 |
| concepts[13].level | 1 |
| concepts[13].score | 0.14850282669067383 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[13].display_name | Immunology |
| keywords[0].id | https://openalex.org/keywords/polyclonal-antibodies |
| keywords[0].score | 0.9170691967010498 |
| keywords[0].display_name | Polyclonal antibodies |
| keywords[1].id | https://openalex.org/keywords/antiserum |
| keywords[1].score | 0.7502971887588501 |
| keywords[1].display_name | Antiserum |
| keywords[2].id | https://openalex.org/keywords/alkaline-phosphatase |
| keywords[2].score | 0.735133171081543 |
| keywords[2].display_name | Alkaline phosphatase |
| keywords[3].id | https://openalex.org/keywords/antibody |
| keywords[3].score | 0.6083718538284302 |
| keywords[3].display_name | Antibody |
| keywords[4].id | https://openalex.org/keywords/saliva |
| keywords[4].score | 0.5668473839759827 |
| keywords[4].display_name | Saliva |
| keywords[5].id | https://openalex.org/keywords/molecular-biology |
| keywords[5].score | 0.48905977606773376 |
| keywords[5].display_name | Molecular biology |
| keywords[6].id | https://openalex.org/keywords/lactate-dehydrogenase |
| keywords[6].score | 0.48729407787323 |
| keywords[6].display_name | Lactate dehydrogenase |
| keywords[7].id | https://openalex.org/keywords/biology |
| keywords[7].score | 0.4377509653568268 |
| keywords[7].display_name | Biology |
| keywords[8].id | https://openalex.org/keywords/transaminase |
| keywords[8].score | 0.4120270907878876 |
| keywords[8].display_name | Transaminase |
| keywords[9].id | https://openalex.org/keywords/chemistry |
| keywords[9].score | 0.40376269817352295 |
| keywords[9].display_name | Chemistry |
| keywords[10].id | https://openalex.org/keywords/biochemistry |
| keywords[10].score | 0.3720472455024719 |
| keywords[10].display_name | Biochemistry |
| keywords[11].id | https://openalex.org/keywords/microbiology |
| keywords[11].score | 0.32297462224960327 |
| keywords[11].display_name | Microbiology |
| keywords[12].id | https://openalex.org/keywords/enzyme |
| keywords[12].score | 0.2071177363395691 |
| keywords[12].display_name | Enzyme |
| keywords[13].id | https://openalex.org/keywords/immunology |
| keywords[13].score | 0.14850282669067383 |
| keywords[13].display_name | Immunology |
| language | en |
| locations[0].id | doi:10.22159/ijpps.2023v15i11.48954 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S2764469077 |
| locations[0].source.issn | 0975-1491, 2656-0097 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 0975-1491 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | International Journal of Pharmacy and Pharmaceutical Sciences |
| locations[0].source.host_organization | https://openalex.org/P4322697801 |
| locations[0].source.host_organization_name | Innovare Academic Sciences |
| locations[0].source.host_organization_lineage | https://openalex.org/P4322697801 |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://journals.innovareacademics.in/index.php/ijpps/article/download/48954/28967 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | International Journal of Pharmacy and Pharmaceutical Sciences |
| locations[0].landing_page_url | https://doi.org/10.22159/ijpps.2023v15i11.48954 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5101458548 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-0914-5380 |
| authorships[0].author.display_name | Nidhi Yadav |
| authorships[0].countries | IN |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I886702836 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Zoology, Deen Dayal Upadhyaya Gorakhpur University, Gorakhpur U. P. India |
| authorships[0].institutions[0].id | https://openalex.org/I886702836 |
| authorships[0].institutions[0].ror | https://ror.org/004wf8x96 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I886702836 |
| authorships[0].institutions[0].country_code | IN |
| authorships[0].institutions[0].display_name | Deen Dayal Upadhyaya Gorakhpur University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | NIDHI YADAV |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Zoology, Deen Dayal Upadhyaya Gorakhpur University, Gorakhpur U. P. India |
| authorships[1].author.id | https://openalex.org/A5103220631 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-1264-3025 |
| authorships[1].author.display_name | Ravi Kant Upadhyay |
| authorships[1].countries | IN |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I886702836 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Zoology, Deen Dayal Upadhyaya Gorakhpur University, Gorakhpur U. P. India |
| authorships[1].institutions[0].id | https://openalex.org/I886702836 |
| authorships[1].institutions[0].ror | https://ror.org/004wf8x96 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I886702836 |
| authorships[1].institutions[0].country_code | IN |
| authorships[1].institutions[0].display_name | Deen Dayal Upadhyaya Gorakhpur University |
| authorships[1].author_position | last |
| authorships[1].raw_author_name | RAVI KANT UPADHYAY |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Zoology, Deen Dayal Upadhyaya Gorakhpur University, Gorakhpur U. P. India |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://journals.innovareacademics.in/index.php/ijpps/article/download/48954/28967 |
| open_access.oa_status | diamond |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | PRODUCTION OF POLYCLONAL ANTIBODIES AGAINST INDIAN CATTLE TICK RHIPICEPHALUS MICROPLUS SALIVA TOXINS AND ITS EFFICACY IN REVERSAL OF TOXIC EFFECTS IN ALBINO MICE |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10296 |
| primary_topic.field.id | https://openalex.org/fields/24 |
| primary_topic.field.display_name | Immunology and Microbiology |
| primary_topic.score | 0.9988999962806702 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2405 |
| primary_topic.subfield.display_name | Parasitology |
| primary_topic.display_name | Vector-borne infectious diseases |
| related_works | https://openalex.org/W2378753434, https://openalex.org/W2383176126, https://openalex.org/W2055681314, https://openalex.org/W2045904278, https://openalex.org/W2386322260, https://openalex.org/W2366122707, https://openalex.org/W2380176342, https://openalex.org/W2099379903, https://openalex.org/W2063673185, https://openalex.org/W2073550346 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.22159/ijpps.2023v15i11.48954 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2764469077 |
| best_oa_location.source.issn | 0975-1491, 2656-0097 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 0975-1491 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | International Journal of Pharmacy and Pharmaceutical Sciences |
| best_oa_location.source.host_organization | https://openalex.org/P4322697801 |
| best_oa_location.source.host_organization_name | Innovare Academic Sciences |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4322697801 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://journals.innovareacademics.in/index.php/ijpps/article/download/48954/28967 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | International Journal of Pharmacy and Pharmaceutical Sciences |
| best_oa_location.landing_page_url | https://doi.org/10.22159/ijpps.2023v15i11.48954 |
| primary_location.id | doi:10.22159/ijpps.2023v15i11.48954 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S2764469077 |
| primary_location.source.issn | 0975-1491, 2656-0097 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 0975-1491 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | International Journal of Pharmacy and Pharmaceutical Sciences |
| primary_location.source.host_organization | https://openalex.org/P4322697801 |
| primary_location.source.host_organization_name | Innovare Academic Sciences |
| primary_location.source.host_organization_lineage | https://openalex.org/P4322697801 |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://journals.innovareacademics.in/index.php/ijpps/article/download/48954/28967 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | International Journal of Pharmacy and Pharmaceutical Sciences |
| primary_location.landing_page_url | https://doi.org/10.22159/ijpps.2023v15i11.48954 |
| publication_date | 2023-11-01 |
| publication_year | 2023 |
| referenced_works | https://openalex.org/W2980182814, https://openalex.org/W3135291450, https://openalex.org/W3000140571, https://openalex.org/W3123939508, https://openalex.org/W4286632927, https://openalex.org/W3132352094, https://openalex.org/W2948318373, https://openalex.org/W2089989500, https://openalex.org/W2014940571, https://openalex.org/W2953855422, https://openalex.org/W3210174580, https://openalex.org/W3188233416, https://openalex.org/W1775749144, https://openalex.org/W2058529640, https://openalex.org/W1861219142, https://openalex.org/W130964878, https://openalex.org/W179256801, https://openalex.org/W1513741126, https://openalex.org/W2168526937, https://openalex.org/W1236809484, https://openalex.org/W2407781290, https://openalex.org/W2263023695, https://openalex.org/W1971048984, https://openalex.org/W4230040883, https://openalex.org/W6777580620, https://openalex.org/W2487216908, https://openalex.org/W2126338751, https://openalex.org/W2027611593, https://openalex.org/W1615320989, https://openalex.org/W1655059953, https://openalex.org/W2615977127, https://openalex.org/W2018163041, https://openalex.org/W1962025604, https://openalex.org/W2058493112, https://openalex.org/W4254305983, https://openalex.org/W2079151017, https://openalex.org/W2022893764, https://openalex.org/W2092490215, https://openalex.org/W79501851, https://openalex.org/W1982814765 |
| referenced_works_count | 40 |
| abstract_inverted_index.6 | 295 |
| abstract_inverted_index.A | 110 |
| abstract_inverted_index.a | 95 |
| abstract_inverted_index.h | 296 |
| abstract_inverted_index.By | 93 |
| abstract_inverted_index.at | 218 |
| abstract_inverted_index.be | 183, 216 |
| abstract_inverted_index.by | 30 |
| abstract_inverted_index.in | 22, 58, 80, 126, 136, 170, 196, 208, 224, 243, 250, 274, 299, 302 |
| abstract_inverted_index.it | 212 |
| abstract_inverted_index.of | 7, 64, 66, 71, 77, 88, 122, 146, 173, 220, 231, 246, 259, 262, 269, 297 |
| abstract_inverted_index.on | 4 |
| abstract_inverted_index.to | 17, 119, 182, 203, 215, 226, 252, 276, 304 |
| abstract_inverted_index.up | 202 |
| abstract_inverted_index.40% | 219, 258 |
| abstract_inverted_index.For | 75 |
| abstract_inverted_index.IgG | 104 |
| abstract_inverted_index.all | 289 |
| abstract_inverted_index.and | 14, 52, 73, 99, 113, 124, 164, 186, 206, 236, 241, 288 |
| abstract_inverted_index.due | 118 |
| abstract_inverted_index.for | 62, 282 |
| abstract_inverted_index.has | 193 |
| abstract_inverted_index.its | 15 |
| abstract_inverted_index.the | 5, 19, 81, 120, 144, 171, 209, 244, 263, 285 |
| abstract_inverted_index.use | 16 |
| abstract_inverted_index.was | 90, 116, 213, 234 |
| abstract_inverted_index.wet | 127 |
| abstract_inverted_index.24-h | 221, 260 |
| abstract_inverted_index.LD50 | 222, 261 |
| abstract_inverted_index.This | 1 |
| abstract_inverted_index.When | 131 |
| abstract_inverted_index.acid | 98, 147 |
| abstract_inverted_index.band | 112, 115 |
| abstract_inverted_index.been | 141, 194 |
| abstract_inverted_index.dose | 223 |
| abstract_inverted_index.five | 59 |
| abstract_inverted_index.from | 108 |
| abstract_inverted_index.gels | 129 |
| abstract_inverted_index.have | 140 |
| abstract_inverted_index.i.e. | 69, 238 |
| abstract_inverted_index.mice | 33, 45, 175, 197, 255, 301 |
| abstract_inverted_index.test | 87 |
| abstract_inverted_index.tick | 11, 55 |
| abstract_inverted_index.were | 28, 34, 46, 106, 134, 180 |
| abstract_inverted_index.with | 36, 40, 48, 54, 177, 199, 257 |
| abstract_inverted_index.(1%). | 130 |
| abstract_inverted_index.(GPT) | 192 |
| abstract_inverted_index.(IDD) | 86 |
| abstract_inverted_index.(LDH) | 163, 272 |
| abstract_inverted_index.after | 294 |
| abstract_inverted_index.found | 181, 214, 237 |
| abstract_inverted_index.level | 230, 273 |
| abstract_inverted_index.mice, | 138 |
| abstract_inverted_index.mice. | 24, 248 |
| abstract_inverted_index.mixed | 39 |
| abstract_inverted_index.serum | 172, 245 |
| abstract_inverted_index.study | 2 |
| abstract_inverted_index.these | 132, 139 |
| abstract_inverted_index.toxic | 20, 67, 286 |
| abstract_inverted_index.while | 211, 254 |
| abstract_inverted_index.(ACP), | 149 |
| abstract_inverted_index.(ALP), | 152 |
| abstract_inverted_index.(GOT), | 160 |
| abstract_inverted_index.(GPT), | 156 |
| abstract_inverted_index.78.37% | 207 |
| abstract_inverted_index.86.48% | 205 |
| abstract_inverted_index.albino | 23, 32, 137, 174, 247, 300 |
| abstract_inverted_index.become | 292 |
| abstract_inverted_index.double | 84 |
| abstract_inverted_index.groups | 61 |
| abstract_inverted_index.immune | 83 |
| abstract_inverted_index.lactic | 161, 232, 270 |
| abstract_inverted_index.levels | 70, 145, 169 |
| abstract_inverted_index.normal | 293 |
| abstract_inverted_index.saliva | 12, 37, 56, 265 |
| abstract_inverted_index.serum, | 210 |
| abstract_inverted_index.toxins | 13, 38, 57, 266 |
| abstract_inverted_index.(AchE). | 166 |
| abstract_inverted_index.102.20% | 242 |
| abstract_inverted_index.116.21% | 217 |
| abstract_inverted_index.117.20% | 268 |
| abstract_inverted_index.94.59%, | 204 |
| abstract_inverted_index.against | 10 |
| abstract_inverted_index.agarose | 128 |
| abstract_inverted_index.antigen | 123 |
| abstract_inverted_index.control | 227 |
| abstract_inverted_index.effects | 21, 287 |
| abstract_inverted_index.focuses | 3 |
| abstract_inverted_index.reverse | 18 |
| abstract_inverted_index.treated | 47, 198 |
| abstract_inverted_index.103.82%, | 240 |
| abstract_inverted_index.104.55%, | 239 |
| abstract_inverted_index.104.71%, | 187 |
| abstract_inverted_index.122.64%, | 184 |
| abstract_inverted_index.Alkaline | 167 |
| abstract_inverted_index.Methods: | 25 |
| abstract_inverted_index.Results: | 92 |
| abstract_inverted_index.alkaline | 150 |
| abstract_inverted_index.ammonium | 100 |
| abstract_inverted_index.control, | 253 |
| abstract_inverted_index.control. | 277, 305 |
| abstract_inverted_index.crescent | 111 |
| abstract_inverted_index.effects, | 68 |
| abstract_inverted_index.enzymes. | 74 |
| abstract_inverted_index.injected | 135, 176, 256 |
| abstract_inverted_index.obtained | 117 |
| abstract_inverted_index.octanoic | 97 |
| abstract_inverted_index.process, | 103 |
| abstract_inverted_index.purified | 264 |
| abstract_inverted_index.pyruvate | 154, 190 |
| abstract_inverted_index.restored | 235 |
| abstract_inverted_index.reversal | 65 |
| abstract_inverted_index.reversed | 143, 195, 284 |
| abstract_inverted_index.sulphate | 101 |
| abstract_inverted_index.107.849%, | 185 |
| abstract_inverted_index.Glutamate | 189 |
| abstract_inverted_index.adjuvant. | 43 |
| abstract_inverted_index.antiserum | 49, 82 |
| abstract_inverted_index.detection | 76 |
| abstract_inverted_index.different | 60 |
| abstract_inverted_index.diffusion | 85 |
| abstract_inverted_index.employing | 94 |
| abstract_inverted_index.followed. | 91 |
| abstract_inverted_index.generated | 29 |
| abstract_inverted_index.glutamate | 153, 157 |
| abstract_inverted_index.immunized | 35 |
| abstract_inverted_index.phosphate | 168 |
| abstract_inverted_index.separated | 107 |
| abstract_inverted_index.treatment | 298 |
| abstract_inverted_index.Freund’s | 42 |
| abstract_inverted_index.Objective: | 0 |
| abstract_inverted_index.Polyclonal | 26, 279 |
| abstract_inverted_index.Similarly, | 229 |
| abstract_inverted_index.antibodies | 9, 27, 79, 105, 125, 133, 179, 201, 280 |
| abstract_inverted_index.antiserum. | 109 |
| abstract_inverted_index.comparison | 225, 251, 275, 303 |
| abstract_inverted_index.generation | 6 |
| abstract_inverted_index.immunizing | 31 |
| abstract_inverted_index.incomplete | 41 |
| abstract_inverted_index.parameters | 291 |
| abstract_inverted_index.polyclonal | 8, 78, 178, 200 |
| abstract_inverted_index.(polyclonal | 50 |
| abstract_inverted_index.Conclusion: | 278 |
| abstract_inverted_index.Ouchterlony | 89 |
| abstract_inverted_index.antibodies) | 51 |
| abstract_inverted_index.biochemical | 290 |
| abstract_inverted_index.interaction | 121 |
| abstract_inverted_index.observation | 63 |
| abstract_inverted_index.phosphatase | 148, 151 |
| abstract_inverted_index.serotherapy | 283 |
| abstract_inverted_index.Experimental | 44 |
| abstract_inverted_index.administered | 281 |
| abstract_inverted_index.demonstrated | 267 |
| abstract_inverted_index.oxaloacetate | 158 |
| abstract_inverted_index.step-by-step | 96 |
| abstract_inverted_index.successfully | 142 |
| abstract_inverted_index.transaminase | 155, 159, 191 |
| abstract_inverted_index.Respectively, | 249 |
| abstract_inverted_index.bio-molecules | 72 |
| abstract_inverted_index.dehydrogenase | 162, 233, 271 |
| abstract_inverted_index.pre-incubated | 53 |
| abstract_inverted_index.precipitation | 102, 114 |
| abstract_inverted_index.respectively. | 188, 228 |
| abstract_inverted_index.acetylcholinesterase | 165 |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 2 |
| citation_normalized_percentile.value | 0.17365429 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |